SEC Form 4 · accession 0001493152-26-028019
ABEONA THERAPEUTICS INC. · ABEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brendan M. O'Malley
Officer — SVP, Chief Legal Officer
Period of report
Jun 8, 2026
Accepted (ET)
Jun 9, 2026 · 8:32 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000318306
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 8, 2026 | S | 4,826 | $5.4295 | D | 446,308 | D | |
| Common StockF3 | Jun 9, 2026 | S | 6,305 | $5.3042 | D | 440,003 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.345 to $5.54 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.24 to $5.47 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.